Orthoclone OKT3 OverviewMuromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants. It is a monoclonal antibody targeted at the CD3 receptor, a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans. Contents 1 History 2 Indications 3 Pharmacodynamics and chemistry ...
Read more Orthoclone OKT3 Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Muromonab-CD3
Recent Orthoclone OKT3 Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 5mg/5ml
- Vial: 1mg/ml